Contribute Try STAT+ Today

E. coli have a bad rap. The very name conjures up mental images — and sounds and smells — of diarrhea and vomiting, but that species of bacterium is actually a kind of golden goose. Even as you’re reading these words, they are teeming in your gut, producing helpful vitamins; in labs around the world, they are filling Petri dishes with offspring, allowing for all kinds of experiments. And at the Massachusetts Institute of Technology, a team of scientists engineered them so that they would turn bright green when they came into contact with certain chemicals.

That sounds really useful, but there is a catch: It was all happening in liquid-filled lab dishes, which hampered many of the real-world applications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.